At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 100 enrolled
Drug / intervention
L-Epinephrine and Normal Saline (0.9%) +1 moredrug
Likely dose
L-Epinephrine and Normal Saline (0.9%) 1.5mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy of Nebulised Hypertonic Saline (3%) Among Children With Mild to Moderately Severe Bronchiolitis - A Double Blind Randomized Controlled Trial.
In Brief
A Phase 4 clinical trial evaluating L-Epinephrine and Normal Saline (0.9%) and L-Epinephrine and Hypertonic Saline (3%) for Bronchiolitis. Completed, enrolled 100 participants across 1 site.
Detailed Summary
To assess the efficacy of nebulized 3% hypertonic saline in improving clinical severity scores among children aged 6 weeks to 24 months with bronchiolitis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBronchiolitis
CountriesNepal
Collaborators--
Timeline
Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2011
First PostedJan 2011
Primary CompletionApr 2011
TodayJul 2026
First PostedJan 13, 2011
Enrollment StartJan 1, 2011
Primary CompletionApr 1, 2011
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 15.5 years ago
Interventions
L-Epinephrine and Normal Saline (0.9%)drug
1.5ml of 1:1,000 L-Epinephrine and 4 ml of 0.9% Normal Saline
L-Epinephrine and Hypertonic Saline (3%)drug
1.5ml of 1:1,000 L-Epinephrine and 4 ml of 3% Hypertonic Saline